BioLineRx CEO Sees Payments: Israel Overnight

BioLineRx Ltd., the Israeli drugmaker that last reported a profit in 2010, expects revenue from royalty payments to grow next year on prospects for drug approvals, according to Chief Executive Officer Kinneret Savitsky.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.